The global healthcare industry stands as a significant contributor to the planet’s carbon footprint, accounting for an estimated 4.4% of…
Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potential
Traumatic Brain Injury (TBI) stands as a formidable global public health crisis, impacting an estimated 69 million individuals annually across…
Read More
Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion
Over the past 16 months, Chinese-domiciled biotechnology companies have emerged as significant players in the global pharmaceutical landscape, securing approximately…
Read More
EClinical Solutions Study Models 241% ROI from AI-Powered Clinical Trial Data Platform
A groundbreaking study, commissioned by clinical trial platform company eClinical Solutions and conducted by independent research firm Hobson & Company,…
Read More
Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…
Read More
A decade in the making: How functional NAMs are redefining cardiac safety assessment
The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…
Read More
BioNTech’s Dramatic Pivot: From €19B COVID Vaccine Fortunes to 1,860 Job Cuts and a €16.8B Oncology Bet
The German biotechnology powerhouse BioNTech, once synonymous with its groundbreaking COVID-19 vaccine Comirnaty, is undergoing a profound strategic transformation, shedding…
Read More
Pharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report Reveals
The pharmaceutical industry, after a period characterized by uneven growth and post-pandemic recalibration, is witnessing a significant upturn in R&D…
Read More
Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent
The Canadian healthcare landscape is poised for a significant transformation with Health Canada’s authorization of Dr. Reddy’s Laboratories’ generic semaglutide…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read MoreYOU MAY HAVE MISSED
